G. Krishna et al., USE OF CYCLOPHOSPHAMIDE AS A POSITIVE CONTROL IN DOMINANT LETHAL AND MICRONUCLEUS ASSAYS, Mutation research. Section on environmental mutagenesis and related subjects, 335(3), 1995, pp. 331-337
Analyses of dominant lethal (DL) mutations and micronuclei (MN) are 2
important and widely used genotoxicity assays to measure drug-induced
chromosome damage in germ cells and somatic cells, respectively. Cyclo
phosphamide (CP) has been widely used as a positive control in the sin
gle-dose mouse MN assay; however, its utility as a positive control fo
r the DL assay has not been fully studied. In the present study, CP wa
s tested in both assays under similar experimental conditions and MN s
een in somatic tissue (bone marrow) were correlated with DL mutations
seen in germinal tissue. In a dose-range finding study, groups of 5 ma
le mice were dosed i.p. daily for 5 days at 0, 30 or 40 mg/kg CP and b
one marrow was harvested 24 h later for MN assay. CP induced a dose-re
lated increase (7- and 11-fold over controls at 30 and 40 mg/kg) in mi
cronucleated polychromatic erythrocytes (MNPCEs) and decreased %PCEs (
to 60% and 54% of controls at 30 and 40 mg/kg, respectively), Based on
this, a definitive DL and MN study was conducted using separate group
s of 30 male mice at 0 and 40 mg/kg CP with a daily times 5 dosing reg
imen. For the MN assay, bone marrow was collected 24 h after the last
dose from 5 animals and evaluated for MNPCEs and %PCEs. For the DL ass
ay, each male was caged with 2 untreated females per week for 8 weeks
to cover the postmeiotic germ cell stages. On day 17 after the initiat
ion of breeding, the females were evaluated for the number of implanta
tion sites and live, dead and resorbed implants. The results indicated
that CP induced about a 17-fold increase in MNPCEs and a 46% decrease
in PCEs in relation to controls. In the DL assay, CP produced a sligh
t (13%) but statistically significant reduction in fertility index at
week 7 of mating. Also, the total number of implants was significantly
lower during weeks 1, 2, 3, 6 and 7 and the numbers of dead implants
and postimplantation loss (PIL) were increased for weeks 1, 2 and 3 (5
5%, 71% and 34% PIL, respectively) over controls. These data clearly s
how that CP produced clastogenicity and some toxicity in both somatic
tissue and germinal tissue. It was concluded that a dose of 40 mg/kg C
P can be used as a positive control compound in the DL assay and in th
e multiple-dose bone marrow MN assay.